Clinical Trial Update: A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of a long-term safety extension study of mavacamten in adults who completed MAVERICK-HCM or EXPLORER-HCM. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Non-obstructive Hypertrophic Cardiomyopathy
• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• Mavacamten (mavacamten)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy | Phase 2, Phase 3 | Status: COMPLETED